HPV Vaccines – Do the Risks Outweigh the Benefits?

Print  | 

North Hollywood, CA, April 22, 2010 — In the August 2009 issue of JAMA. 2009;302(7):795-796.; Journal of the American Medical Association, Charlotte Haugh, MD, PhD, MCs, posed an interesting question regarding Gardasil® and Cervarix®: “When do physicians know enough about the beneficial effectsof a new medical intervention to start recommending or usingit? When is the available information about harmful adverseeffects sufficient to conclude that the risks outweigh the potentialbenefits?

Members of TruthaboutGardasil.org believe the risks from HPV vaccines outweigh any benefits. Approximately 18,000 adverse reactions, 67 deaths, and 272 cases of abnormal pap tests up to two years post-vaccination have been reported to the Vaccine Adverse Event Reporting System (VAERS). However, according to the National Vaccine Information Center (NVIC) only 1 to 10 percent of the adverse events are reported.

Why such a low percentage? Adverse reactions and deaths in many cases have not been linked to HPV vaccines, and are noted by physicians as “mystery illnesses.”

Dr. Haugh writes: “Whether a risk is worth taking depends not only on the absoluterisk, but on the relationship between the potential risk andthe potential benefit. If the potential benefits are substantial,most individuals would be willing to accept the risks. But thenet benefit of the HPV vaccine to a woman is uncertain. Evenif persistently infected with HPV, a woman most likely willnot develop cancer if she is regularly screened. So rationallyshe should be willing to accept only a small risk of harmfuleffects from the vaccine.”

The JAMA article states that risks from HPV vaccination include: anaphylaxis, Guillain-Barr syndrome,transverse myelitis, pancreatitis, and venous thromboembolicevents. Additional VAERS reports include: nausea, dizziness, epileptic seizures, extreme pain in joints, paralysis, palpitations, tingling, numbness, brain fog, weak legs, loss of vision, hair loss, bloody stools, vomiting blood, hyperpigmented plaques overlying the vessels, degenerative disk disease, loss of peripheral vision, slurred speech, loss of motor movement, enlarged liver, sleep apnea, menstrual cycle disruption, ruptured ovarian cysts, enlarged fallopian tubes, bleeding/enlarged or complex ovarian cyst, migraines, and back pain.

Not one girl, who has been adversely injured by the HPV vaccines, has fully recovered from her illnesses. According to NVIC Director Barb Loe Fisher, “The biological mechanisms for potential brain/immune system damage caused by Gardasil and Cervarix are likely multi-factoral and related to individual host characteristics; genes, health at time of vaccination, which includes menstrual status; previous vaccine reactions; co-exposure to other environmental toxins; etc.” Howcan the use of a one-size-fits-all-vaccine be justified based on this?

Dr. Haugh closes her article by stating, “When weighing evidence about risks and benefits, it is alsoappropriate to ask who takes the risk, and who gets the benefit?”

Members of TruthAboutGardasil.org advocate public health policies mandating that girls and their parents be fully informed about the potential risks, all reported adverse events, and be given the vaccine package insert to read prior to inoculations.

Other press releases from Bobbi Cowan Public Relations

• Women Look to India for Answers about HPV Vaccine Dangers - April 16th, 2010